INTRODUCTION
The 1,2,4-triazole(4H) derivatives, which are used in this study, play an important role in medicinal chemistry and are useful templates for further development through modification or derivatization to design more potent biologically active compounds. 1,2,4-Triazole is an important group in heterocyclic compounds because of wide range of therapeutically importance used in a wide variety of medicines e.g. Ribavarin, (an antiviral drug), Rizatriptan (an antimagraine), Alprazolam (an anxiolytic), Vorozole, Letrozole and Anastrozole (antitumoral) are some examples of these drugs (1) . A large number of research has been carried out on 1,2,4-triazole(4H) and their derivatives, which have proved the pharmacological importance of these heterocyclic nucleus (2-6). Although they have been known from long ago as biologically active, their varied biological features are still interesting for science. An additional advantage of this group of substances is the relative simplicity of their synthesis. Previously, we have synthesized derivatives of 3-mercapto-1,2,4-triazole containing in 5 position phenoxymethyl and in 4 position benzyl or allyl residues (7) (8) . A number of them have shown interesting pharmacological properties, one of them has anti-ulcer activity (7) (8) . We were interested to see how the replacement of benzyl or allyl residues to phenyl in 4 position influences on the pharmacological properties. The purpose of this work is the synthesis of new derivatives of 1,2,4(4Н) triazoles, prediction of their probable anti-ulcer activity by the computer program PASS, conducting the docking study, and comparison of their anti-ul-
MATERIALS AND METHODS
Synthetic strategy of this study is the structure modification of 1,2,4-triazole(4H) ring scaffolds in the positions 1, 2 and 5 with the aim of obtaining more potent pharmacologically active compounds. All research chemicals were purchased from the Sigma-Aldrich (USA) and used as such for the reactions. Several key types of the reactions were generally used us that allowed to obtain new started mercaptotriazoles 6a-b (9) . The synthesis of 6a-b was carried out from the corresponding phenols 1a-b due to Scheme 1.
Resulting from the alkylation of ethyl chloroacetate and subsequent hydrazinolysis substituted phenoxyacetic acid hydrazides 3a-b were involved into interaction with phenylisothiocyanates 4 with vigorous stirring in ethanol. Reactions were monitored by thin layer chromatography carried out using pre-coated silica gel plates (E. Merck and Co., Darmstadt, Germany).
The reaction mixture was heated to reflux, cooled and the precipitate of formed substituted phenylthiosemicarbazides 5a-b was filtered out and dried. Phenylthiosemicarbazides synthesized were cyclized in the presence of alkali. The reaction mixture was refluxed. After cooling, the solution was acidified with hydrochloric acid to pH = 3-4. The resulting precipitate was the corresponding 4-aryl-5-phenoxymethyl-3-mercapto-1,2,4-triazoles 6a-b was filtered, washed with water and dried. The existence of thiol-thione tautomerism is known for the compounds 6a-b, and thione forms predominates according to the data of NMR spectroscopy. To further transformations mercaptotriazoles synthesised 6a-b were alkylated by chloroacetophenones 7a-f in a homogeneous base catalysis conditions, resulting to the compounds 4-phenyl-5-4-(R)-phenoxymethyl-1,2,4-triazole-3-ylthio-1-(R 1 )-acetophenones 8a-f (Scheme 1). Structures of compounds were confirmed via their spectral data. The 1 H NMR spectra were obtained on an NMR Spectrophotometer (Bruker Avance II 200 NMR) using DMSO-d6 as a solvent. Chemical shifts were expressed in parts per million relative to TMS as an internal standard.
All substances 8a-f have been tested for compliance with Lipinski's rule of five (a set of physical Scheme 1 and chemical properties meet modern requirements that apply to new compounds under testing their biological activity) by the computer program ACD / Labs (10) . The probability of anti-ulcer activity of the newly synthesized substances was simulated by the computer program PASS (Prediction of Activity Spectra for Substances) (11) .
Molecular docking and anti-ulcer screening of new 4-phenyl-5-4-(R)-phenoxymethyl-1,2,4-triazole-3-ylthio-1-(R 1 )-acetophenones have been performed. Docking was carried out by taking of proteins membrane histamine H 2 receptor (PDB ID: 1U19), human gastric pathogen helicobacter pylori (PDB ID: 3 UX4) and the human microsomal prostaglandin E enzyme synthase 1(MPGES1) domains (PDB ID: 3DWW) as a targets for anti-ulcer activity (12) (13) (14) (15) . Since Black et al. first defined the H 2 R receptor and its involvement in gastric acid secretion, H 2 R antagonists (e.g., cimetidine, ranitidine, famotidine) have been developed and used clinically as antiacid secretagogues. These histamine H 2 R antagonists have revolutionized the treatment of peptic ulcers with their prominent therapeutic effects. Prostaglandins have anti-secretory effect on gastric acid and protect the lining of the stomach from the damaging effects of the acid. Therefore, ligands which can prevent rapid metabolic conversion prostaglandins into inactive products may be used for treating of NSAID-inducеd ulcer. Half the world's population is chronically infected with Helicobacter pylori, causing gastritis, gastric ulcers and an increased incidence of gastric adenocarcinoma. Therefore, human gastric pathogen helicobacter pylori (PDB ID: 3UX4) also can be used as target. The docking simulations were performed by the SCIGRESS program (16) . Fast docking method, in which receptor is rigid and ligands are flexible, was adopted and binding energy values were compared with each other.
All chemical structures 8a-f were generated using ISIS DRAW 4.0 software. The docking study was performed using Scigress Explorer 7.7 installed on a single machine running on a 3.4 GHz Intel Core 2 Duo Processor with 1GB RAM and 160 GB Hard Disk with Windows XP as Operating System. Ligands structures 8a-f were drawn on Scigress Explorer using standard bond, lengths and angles. The ligands were stored in .csf format. The proteins modeled using the electron crystallographic structure at 3.5Å resolution was downloaded from the RCSB Protein Data Bank (PDB ID: 1U19, 3DWW, 3UX4). Before the docking water molecules were removed and hydrogen was added to the crystal structure of proteins. After assigning charge and protonation state final refinement (energy minimization) was done using MM3 force field runs. Energy minimization or complex optimization was done for molecular docking calculations and to optimize geometries within the binding site. Complex optimization gave us ligands with minimum energy pose within the active site cavity of the proteins. At the end of the docking study, the minimum Consensus scores for the best positions for each of ligands were obtained.
Obtained 6 heterocyclic compounds became an object for study concerning anti-ulcer activity (17) . The study of anti-ulcer activity of the synthesized compounds was carried out using mongrel white rats of both sexes weighing 180-280 g, which previously were stood in a starvation diet for 24 hours without limitation of drinking water. Acute ethanol-prednisolone gastric ulcer of rats was induced by disposable intragastric administration of ethanol -prednisolone mixture (prednisolone at a dose of 20 mg/kg and ethanol (80 %) at the rate of 0.6 ml per 100 g of rat).
The test substance was administered intragastrically at a dose (20 mg/kg), a reference drug -ranitidine at a dose 40 mg/kg in a preventive mode for 1 hour prior to administration ethanol -prednisolone mixture. At the end of the experiment the animals were taken out of the experiment (24 hours after administration of ulcerogenic agent) under conditions of euthanasia. The stomachs were removed, cut, washed with saline and conducted macroscopic study of the gastric mucosa. Assessment of intensity of ulcerative lesions and anti-ulcer activity of the preparations was carried out by the state of macroscopic parameters of the mucous membrane of the stomach and gastrointestinal tract, and the intensity of the formation of ulcer:
1. The percentage of animals with ulcers (PA); 2. The average size of ulcers in a group (SU); 3. Ulcer Index (UI); 4. Anti-ulcer activity (AUA, %). Furthermore, in the process of analyzing the experimental results, external appearance and general condition of the animals were taken into ac-count. Indicators of the state of the gastrointestinal tract and mucous membrane of the stomach, namely a swelling of the stomach and intestines, hyperemia, hemorrhage, edema, folding disorders were assessed for their severity in points: 0 points -there is no sign, 1 points -the sign is weak, 2 points -moderate, 3 points -much.
Ulcerative index and anti-ulcer activity were calculated by the formula: UI = (SU × PA)/100 AUA, %=100% -((UI (t) ×100%)/ UI(c)), where UI (t) -UI in the group of animals with model pathology, which are treated, UI (c) -UI in the group of animals with control pathology, which are not treated.
Ranitidine was chosen as the reference drug, the active ingredient of which is N- (18) . Ranitidine is included in the National Drug Formularynamely the list of drugs for the treatment of peptic ulcer disease and its experimental dose has been taken from the literature (18) . The experimental doses of the test substances are corresponded to previously established conditionally therapeutic dose of thiotriazoline.
RESULTS
All synthesized compounds 4-phenyl-5-(4-R-phenoxymethyl-1,2,4-triazole-3-ylthio-1-(R 1 )-acetophenone 8a-f after crystallization from ethanol are white crystalline substances with clear melting points, soluble in organic solvents. Melting points (mp) were determined on a Kofler melting point apparatus. Physical properties and other data are shown in Table 1 . The structure of compounds 8a-f was confirmed by 1 H NMR spectroscopy (19) . The mercaptogroup proton signal after alkylation disappears in compounds 8a-f. The signals of aromatic protons were observed in the ranges 6.75-8.20 ppm. As shown in Table 2 , the signals of both methylene groups associated with sulfur and oxygen atom are common and occur. Due to the absence of protons in their surroundings they look like singlet. The signals of methylene groups have been interpreted by us in accordance with the electronegativity of neighboring atoms so -signals at 5.28-5.29 ppm has been attributed to the presence of a group OCH 2 ; at 5.15-5.18 ppm -group SCH 2 . Methyl groups of the tert-butyl residue are shown on the spectra as a single signal intensity in 9 protons at 1.20-1.25 ppm.
We can presume on the base of the data obtained by the computer program PASS that all compounds of this group (8a-f) may exhibit high anti-ulcer probable activity (Pa) by inhibition of histamine H 2-receptor (from 0.52 to 0.69) and anti-helicobacter activity (Pa from 0.50 to 0.65), which served as a primary screen and are listed in Table 3 . The most promising substance 8b (maximum activity index 0.69) is observed when introduced into the molecule simul- Table 3 .
Anti-ulcer activity preliminary screening results for tested compounds at one dose assay are shown in Table 4 . The studies found that 5 of the 6 tested substances have anti-ulcer activity at the level of the reference drug ranitidine.
DISCUSSION
All prescreened ligands 4-phenyl-5-4-(R)-phenoxymethyl-1,2,4-triazole-3-ylthio-1-(R 1 )-acetophenones had docking scores in the receptor cavity (1U19) greater than that of ranitidine (-35.84 kcal/ mol) indicating that they bind the target better.
Results of the docking have shown that molecule 8b has a dock score better in the receptor cavity (1U19) than the others (highest negative dock score -79.3) (Fig. 1) .
It means that it can fit well forming the most energetically stable drug receptor complex. The best possible binding modes of the 8b at targeted protein's 1U19 active sites are displayed in Fig. 2 .
All tested ligands had docking scores in the receptor cavity (3DWW) down the level of mysoprostol (-46.51 kcal/mol) indicating that they bind the target better.
When analyzing the docking results it is worth to mention that compounds 1,2,4-triazole(4H) derivatives 8a, 8b, 8c, 8d and 8e have anti-ulcer activity.
In our research experiment in vivo five derivatives of 1,2,4-triazole (compounds tested 8a, 8b, 8c, 8d and 8e) significantly prevented the gastric acid secretion and gastric-ulcer formation, similar to the ranitidine effect. Our results demonstrate that all tested substances effectively inhibit gastric acid secretion and protect the gastric mucosal layer in a manner similar to that of other H 2 R antagonists.
Compound tested 8f in one-dose primary assay did not show any impressive anti-ulcer activity and therefore can't be considered as prospective anti-ulcer agent. Results of studies have shown that utilization of phenoxymethyl and phenyl residue for the structure optimization of 1,2,4-triazole(4H) scaffolds is an effective approach in novel anti-ulcer agents design and may be taken as the variant of hybrid pharmacophore approach. 
